Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin J Edelman

Showing results (151-160 of 186) with videos related to

Pageof 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2012
Phase I study of folate conjugate EC145 (Vintafolide) in patients with refractory solid tumorsPatricia M Lorusso, Martin J Edelman, Susan L Bever, et al.
JAMA Oncology|April 11, 2024
American Radium Society Appropriate Use Criteria for Unresectable Locally Advanced Non-Small Cell Lung CancerGeorge Rodrigues, Kristin A Higgins, Andreas Rimner, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 13, 2021
Harmonized Outcome Measures for Use in Non-Small Cell Lung Cancer Patient Registries and Clinical PracticeMartin J Edelman, Daniel P Raymond, Dwight H Owen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 3, 2018
Time-to-Treatment-Failure and Related Outcomes Among 1000+ Advanced Non-Small Cell Lung Cancer Patients: Comparisons Between Older Versus Younger Patients (Alliance A151711)Ajeet Gajra, Tyler J Zemla, Aminah Jatoi, et al.
Advances in Radiation Oncology|November 9, 2017
Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancerMelissa A L Vyfhuis, Neha Bhooshan, Whitney M Burrows, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Randomized, double-blind, placebo-controlled, multicenter phase II study of the efficacy and safety of apricoxib in combination with either docetaxel or pemetrexed in patients with biomarker-selected non-small-cell lung cancerMartin J Edelman, Ming T Tan, Mary J Fidler, et al.
Clinical Lung Cancer|October 20, 2018
Lymph Node Size Predicts for Asymptomatic Brain Metastases in Patients With Non-small-cell Lung Cancer at DiagnosisStephanie R Rice, Jason K Molitoris, Melissa A L Vyfhuis, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 9, 2006
Promoter methylation and response to chemotherapy and radiation in esophageal cancerJames P Hamilton, Fumiaki Sato, Bruce D Greenwald, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 9, 2020
American Radium Society Appropriate Use Criteria: Radiation Therapy for Limited-Stage SCLC 2020Stephen G Chun, Charles B Simone, Arya Amini, et al.
JAMA Oncology|June 1, 2018
Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 TrialRobert D Timmerman, Rebecca Paulus, Harvey I Pass, et al.
Pageof 19

Showing results (151-160 of 186) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2012
Phase I study of folate conjugate EC145 (Vintafolide) in patients with refractory solid tumorsPatricia M Lorusso, Martin J Edelman, Susan L Bever, et al.
JAMA Oncology|April 11, 2024
American Radium Society Appropriate Use Criteria for Unresectable Locally Advanced Non-Small Cell Lung CancerGeorge Rodrigues, Kristin A Higgins, Andreas Rimner, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 13, 2021
Harmonized Outcome Measures for Use in Non-Small Cell Lung Cancer Patient Registries and Clinical PracticeMartin J Edelman, Daniel P Raymond, Dwight H Owen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 3, 2018
Time-to-Treatment-Failure and Related Outcomes Among 1000+ Advanced Non-Small Cell Lung Cancer Patients: Comparisons Between Older Versus Younger Patients (Alliance A151711)Ajeet Gajra, Tyler J Zemla, Aminah Jatoi, et al.
Advances in Radiation Oncology|November 9, 2017
Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancerMelissa A L Vyfhuis, Neha Bhooshan, Whitney M Burrows, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Randomized, double-blind, placebo-controlled, multicenter phase II study of the efficacy and safety of apricoxib in combination with either docetaxel or pemetrexed in patients with biomarker-selected non-small-cell lung cancerMartin J Edelman, Ming T Tan, Mary J Fidler, et al.
Clinical Lung Cancer|October 20, 2018
Lymph Node Size Predicts for Asymptomatic Brain Metastases in Patients With Non-small-cell Lung Cancer at DiagnosisStephanie R Rice, Jason K Molitoris, Melissa A L Vyfhuis, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 9, 2006
Promoter methylation and response to chemotherapy and radiation in esophageal cancerJames P Hamilton, Fumiaki Sato, Bruce D Greenwald, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 9, 2020
American Radium Society Appropriate Use Criteria: Radiation Therapy for Limited-Stage SCLC 2020Stephen G Chun, Charles B Simone, Arya Amini, et al.
JAMA Oncology|June 1, 2018
Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 TrialRobert D Timmerman, Rebecca Paulus, Harvey I Pass, et al.
Pageof 19